NASDAQ: CDT · Life Sciences · 8 alerts · CIK 1896212
Share price
$0.3770Close, Nov 16
Market cap
$2.38M
Shares outstanding
6.31MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CDT Equity Inc. filings on SEC EDGAR ↗
CDT Equity Inc. stockholders approved a proposal to authorize the board of directors to effect a reverse stock split at a ratio ranging from 1-for-2 to 1-for-100. Stockholders also approved the issuance of common stock under Nasdaq Listing Rule 5635 related to convertible notes and warrants issued to J.J. Astor & Co.
CDT Equity Inc. has filed a certificate of amendment to effectuate a 1-for-20 reverse stock split of its common stock, effective November 5, 2026. The split is intended to maintain compliance with Nasdaq Listing Rules, reducing the outstanding share count from approximately 20.4 million to 1.0 million shares. Trading on a split-adjusted basis is expected to begin on November 6, 2026, under the existing ticker symbol 'CDT'.
CDT Equity Inc. has announced a 1-for-25 reverse stock split of its common stock, effective September 28, 2026. The split is intended to increase the per-share price to ensure continued compliance with the Nasdaq minimum bid-price requirement. Trading on a split-adjusted basis is expected to begin on September 29, 2026, reducing the outstanding share count to approximately 1.12 million shares.